Methods of manufacturing contact lenses for delivery of beneficial agents
View Patent ↗Contact lenses comprising an ionic component are packaged with a beneficial cationic agent in a temperature-sensitive packaging solution and/or a low ionic strength packaging solution.
1. A method of manufacturing a contact lens, said method comprising:
a) polymerizing a monomer mixture comprising at least one carboxylic-acid containing monomer to form a lens-shaped polymerization product comprising carboxylic acid groups;
b) placing the lens-shaped polymerization product in a package containing a packaging solution comprising a buffer and a beneficial cationic agent, wherein said packaging solution has an osmolality of about 200 to about 400 mOsm/kg, and wherein said packaging solution i) has an ionic strength of less than about 0.1, or ii) is temperature-sensitive, or iii) has an ionic strength of less than about 0.1 and is temperature-sensitive; and
c) sealing and autoclaving the package to provide a sterile packaged contact lens, wherein the beneficial cationic agent ionically binds to the carboxylic acid groups and releases from the contact lens in an in vitro release assay;
wherein at least 50% more of the cationic agent is taken up by the lens compared to an identical contact lens packaged in PBS.
2. The method of claim 1 , wherein the carboxylic-acid containing monomer is methacrylic acid.
3. The method of claim 1 , wherein the contact lens comprises from about 0.5 to about 2.5% methacrylic acid.
4. The method of claim 3 , wherein the methacrylic acid is the only ionic monomer in the monomer mixture.
5. The method of claim 1 , wherein the monomer mixture comprises a silicone monomer.
6. The method of claim 1 , wherein the monomer mixture comprises 2-hydroxyethyl methacrylate.
7. The method of claim 1 , wherein the ionic strength of the packaging solution is less than 0.1.
8. The method of claim 1 , wherein the ionic strength of the packaging solution is less than 0.06.
9. The method of claim 1 , wherein in the packaging solution comprises a non-electrolyte tonicity adjusting agent.
10. The method of claim 9 , wherein the tonicity adjusting agent is sorbitol.
11. The method of claim 1 , wherein the packaging solution has an osmolality of about 270 to about 310 mOsm/kg.
12. The method of claim 1 , wherein the cationic agent is a polymer.
13. The method of claim 1 , wherein the cationic agent is an ophthalmic drug.
14. The method of claim 1 , wherein the packaging solution comprises a temperature-sensitive buffer and the cationic agent is autoclave-stable in the packaging solution and is not autoclave-stable in PBS.
15. The method of claim 14 , wherein the temperature-sensitive buffer comprises a buffering agent selected from {[tris(hydroxymethyl)methyl]amino}propanesulfonic acid (TAPS), N,N-bis(21-hydroxyethyl)glycine (Bicine), tris(hycroxymethyl)methylamine (TRIS), N-tris(hydroxymethyl)methylglycine (Tricine), [tris(hydroxymethyl)methyl]amino}ethanesulfonic acid (TES), 3-(N-morpholino)propanesulfonic acid (MOPS), and any combination thereof.
16. The method of claim 14 , wherein the temperature-sensitive buffer comprises a TRIS buffer.
17. The method of claim 14 , wherein the cationic agent comprises a primary amine.
18. The method of claim 14 , wherein the cationic agent is epinastine and/or εPLL.
19. The method of claim 1 , further comprising storing the contact lens after it has been worn by a patient in a multi-purpose contact lens care solution (MPS) that comprises an additional amount of the cationic agent, wherein the storage solution has an osmolality of about 200 to about 400 mOsm/kg and has an ionic strength of less than about 0.1, wherein the additional cationic agent incorporates into the contact lens during the storage.
20. A contact lens made by the method of claim 1 .